L-ornithine derived polyamines in cystic fibrosis airways
about
Neutrophil plasticity enables the development of pathological microenvironments: implications for cystic fibrosis airway diseaseAsymmetric dimethylarginine in chronic obstructive pulmonary disease (ADMA in COPD)Multitracer stable isotope quantification of arginase and nitric oxide synthase activity in a mouse model of pseudomonas lung infection.Immunohistochemical detection of arginase-I expression in formalin-fixed lung and other tissuesMetabolomic Evaluation of Neutrophilic Airway Inflammation in Cystic Fibrosis.Evolutionary genomics of epidemic and nonepidemic strains of Pseudomonas aeruginosa.Metabolomic biomarkers predictive of early structural lung disease in cystic fibrosis.Oscillatory shear stress-induced arginase activity may explain reduced exhaled nitric oxide levels after vest chest physiotherapy in cystic fibrosis.Gamma-Glutamylpolyamine Synthetase GlnA3 Is Involved in the First Step of Polyamine Degradation Pathway in Streptomyces coelicolor M145.Putrescine reduces antibiotic-induced oxidative stress as a mechanism of modulation of antibiotic resistance in Burkholderia cenocepacia.Elucidating the Structure of N1-Acetylisoputreanine: A Novel Polyamine Catabolite in Human Urine.Concentration-dependent activity of antibiotics in natural environments.Mapping targetable inflammation and outcomes with cystic fibrosis biomarkers.Role of Polyamines in Asthma Pathophysiology.Lung arginase expression and activity is increased in cystic fibrosis mouse models.
P2860
Q28071357-1479E8E3-9A57-4E29-AFEA-AAE73550FABFQ33580586-274BFAE4-8EC2-4F30-B069-F91E69B19E97Q34081594-383E838C-BD41-4CA0-9AE4-F99357D09D61Q34359945-145069C6-1FF0-4DBD-A632-4BBAE2D03A74Q35914614-29B57BB9-8D8E-48FB-92DD-2A187F9267BDQ37421177-4A457512-0606-4F98-AE01-40700797D331Q38796210-F7E8BC23-A03B-4C9C-8EB8-CB6E53B98379Q38922339-5372DD12-2651-44C0-86AE-4673777E20E6Q40219520-27716F48-8BBC-4B4B-97DD-A685F872433BQ41080175-7E82EDCB-5A58-4974-8A32-6D65FFAE574DQ41194548-D02527BB-63F9-4164-B28A-84486B435F70Q43245583-459C8529-DE66-4150-9B24-78903E7DF315Q47831284-367CB2AC-0F02-4174-8107-84FDE74CBF04Q48278516-4B2161B9-F972-4172-B235-B572BD672002Q51717187-FA94DCF6-367F-4C30-9E47-ED2AF43D3FD7
P2860
L-ornithine derived polyamines in cystic fibrosis airways
description
2012 nî lūn-bûn
@nan
2012 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
L-ornithine derived polyamines in cystic fibrosis airways
@ast
L-ornithine derived polyamines in cystic fibrosis airways
@en
L-ornithine derived polyamines in cystic fibrosis airways
@nl
type
label
L-ornithine derived polyamines in cystic fibrosis airways
@ast
L-ornithine derived polyamines in cystic fibrosis airways
@en
L-ornithine derived polyamines in cystic fibrosis airways
@nl
prefLabel
L-ornithine derived polyamines in cystic fibrosis airways
@ast
L-ornithine derived polyamines in cystic fibrosis airways
@en
L-ornithine derived polyamines in cystic fibrosis airways
@nl
P2093
P2860
P1433
P1476
L-ornithine derived polyamines in cystic fibrosis airways
@en
P2093
Darakhshanda Shehnaz
Hartmut Grasemann
Jaques Belik
Masahiro Enomoto
Michael Leadley
P2860
P304
P356
10.1371/JOURNAL.PONE.0046618
P407
P50
P577
2012-10-05T00:00:00Z